Changchun High-Tech Industries (Group) Inc.
000661
주식 순위
#3898
Changchun High-Tech Industries (Group) Inc., operating with its various... Changchun High-Tech Industries (Group) Inc., operating with its various subsidiaries, is primarily involved in the production and distribution of biopharmaceutical products and traditional Chinese medicines across the Chinese market. Additionally, the company diversifies its activities into property development, real estate management, and leasing services. Founded in Changchun, China, in 1993, this enterprise was previously known as Changchun High & New Technology Industry (Group) Inc.
주가
$10.24
시가총액
$4.18B
변동 (1일)
-1.10%
변동 (1년)
-38.73%
국가
CN
거래 Changchun High-Tech Industries (Group) Inc. (000661)
카테고리
Healthcare
Changchun High-Tech Industries (Group) Inc. (000661)의 매출
Jun 2026 기준 매출 TTM: $1.65B
Changchun High-Tech Industries (Group) Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 $1.65B입니다. 2024년에 회사는 $1.84B의 수익을 올렸으며 이는 2023년의 $2.06B 대비 감소입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
Changchun High-Tech Industries (Group) Inc.의 수익 기록 (2001 ~ 2026)
매년 말 매출
| 연도 | 매출 | 변화 |
|---|---|---|
| 2026 (TTM) | $1.65B | -4.43% |
| 2025 | $1.73B | -6.38% |
| 2024 | $1.84B | -10.35% |
| 2023 | $2.06B | 12.41% |
| 2022 | $1.83B | 8.27% |
| 2021 | $1.69B | 28.79% |
| 2020 | $1.31B | 23.98% |
| 2019 | $1.06B | 35.52% |
| 2018 | $781.41M | 23.93% |
| 2017 | $630.52M | 51.09% |
| 2016 | $417.32M | 12.82% |
| 2015 | $369.91M | 1.28% |
| 2014 | $365.24M | 8.14% |
| 2013 | $337.75M | 19.59% |
| 2012 | $282.43M | 37.53% |
| 2011 | $205.36M | 16.25% |
| 2010 | $176.65M | 17.82% |
| 2009 | $149.93M | 27.22% |
| 2008 | $117.85M | 29.97% |
| 2007 | $90.67M | 21.94% |
| 2006 | $74.36M | 23.28% |
| 2005 | $60.32M | 36.19% |
| 2004 | $44.29M | -13.59% |
| 2003 | $51.25M | -8.14% |
| 2002 | $55.79M | 13.53% |
| 2001 | $49.14M | 0.00% |
유사 기업 또는 경쟁사의 매출
| 회사 | 매출 | 매출 차이 | 국가 |
|---|---|---|---|
| $12.62B | 664.82% |
US
|
|
| $2.23B | 34.98% |
US
|
|
| $15.74B | 853.84% |
AU
|
|
| $9.57B | 479.94% |
BE
|
|
| $6.02B | 264.79% |
NL
|
